|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/30 | |||
| A61P 35/00 | |||
| C07K 16/32 | |||
| A61K 39/00 |
| (11) | Patento numeris | 2237792 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08865503.0 |
| Europos patento paraiškos padavimo data | 2008-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/013998 |
| Data | 2008-12-23 |
| (87) | Numeris | WO 2009/082485 |
| Data | 2009-07-02 |
| (30) | Numeris | Data | Šalis |
| 16763 P | 2007-12-26 | US |
| (72) |
ZAUDERER, Maurice, US
EVANS, Elizabeth, E., US
|
| (73) |
Vaccinex, Inc.,
1895 Mt. Hope Avenue, Rochester, NY 14620,
US
|
| (54) | ANTI-C35 ANTIBODY COMBINATION THERAPIES AND METHODS |
| ANTI-C35 ANTIBODY COMBINATION THERAPIES AND METHODS |